or
forgot password
  • cancer clinical trials in houston, TX

  • U19 Project 1 (Targretin Effect on Breast Cancer)
    MDACC
    Houston, Texas 77030
    Breast Cancer
    Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients
    Baylor Breast Center
    Houston, Texas 77030
    Breast Cancer
    An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Advanced Cancer
    Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Cervical Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    Ben Taub General Hospital
    Methodist Hospital
    M D Anderson Cancer Center
    Veterans Administration Medical Center
    Saint Luke's Episcopal Hospital
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
    M.D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030
    Pancreatic Cancer
    Cetuximab With or Without Carboplatin in Treating Women With Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer
    Baylor University Medical Center - Houston

    Trial Locations
    Baylor University Medical Center - Houston
    M. D. Anderson Cancer Center at University of Texas
    Breast Cancer
    N2001-02: I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
    Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital
    Houston, Texas 77030-2399
    Neuroblastoma
    Neoadjuvant, Tarceva, Surgery for Non-Small Cell Lung Cancer (NSCLC)
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Lung Cancer
    Study of Dasatinib in Patients With Chronic Myelogenous Leukemia
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Chronic Myelogenous Leukemia
    Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
    The University of Texas M.D. Anderson Cancer Center
    Houston, Texas
    Acute Myeloid Leukemia, Myelodysplastic Syndromes, Agnogenic Myeloid Metaplasia, Myelofibrosis, Hypereosinophilic Syndrome, Polycythemia Vera, Mastocytosis, Leukemia, Myelomonocytic, Chronic
    Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Lymphoma
    Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
    Pfizer Investigational Site
    Houston, Texas 77030
    Chronic Myeloid Leukemia
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    M D Anderson Cancer Center
    Houston, Texas 77030
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    M D Anderson Cancer Center
    Houston, Texas 77030
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Breast Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Veterans Affairs Medical Center - Houston

    Trial Locations
    Veterans Affairs Medical Center - Houston
    Baylor University Medical Center - Houston
    Ben Taub General Hospital
    St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital
    Colorectal Cancer
    Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Acute Lymphocytic Leukemia
    Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer
    UT MD Anderson Cancer Center

    Trial Locations
    UT MD Anderson Cancer Center
    Lyndon Baines Johnson General Hospital
    Non-Small Cell Lung Cancer
    Bevacizumab in Treating Patients With Angiosarcoma
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Sarcoma
    High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    M.D. Anderson Cancer Center; Transplant site, please contact Baylor College of Medicine
    Multiple Sclerosis
    Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer
    The University of Texas M.D. Anderson Cancer Center
    Houston, Texas
    Prostate Cancer
    Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
    Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital
    Houston, Texas 77030-2399
    Neuroblastoma
    Group Therapy for Nicotine Dependence: Mindfulness and Smoking
    University of Texas MD Anderson Cancer Center
    Houston, Texas 77030
    Smoking, Tobacco Use Cessation
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Melanoma
    SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
    M D Anderson Cancer Center
    Houston, Texas 77030
    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Blastic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Chronic Lymphocytic Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes
    PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML
    The University of Texas M.D. Anderson Cancer Center
    Houston, Texas
    Chronic Myeloid Leukemia
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    Baylor College of Medicine
    Houston, Texas 77030
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Neurofibromatosis Type 1, Sarcoma
    A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma
    MD Anderson Cancer Center/University of Texas StudyCoordinator:CRAF265A2101
    Houston, Texas 77030-4009
    Metastatic Melanoma
    ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
    M. D. Anderson Cancer Center at University of Texas

    Trial Locations
    M. D. Anderson Cancer Center at University of Texas
    Lyndon B. Johnson General Hospital
    Cervical Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    Ben Taub General Hospital
    Methodist Hospital
    M D Anderson Cancer Center
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Fludarabine-based Conditioning for Severe Aplastic Anemia
    University of Texas, MD Anderson CRC
    Houston, Texas 77030
    Anemia, Aplastic
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    Ben Taub General Hospital
    Methodist Hospital
    M D Anderson Cancer Center
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer